[e-drug] Int. conference on stimulating R&D for neglected diseases

E-drug: Int. conference on stimulating R&D for neglected diseases
-------------------------------------------------------------------------
[Please remember to contact Mali directly, NOT via E-drug. Watch your
button! KM]

     CONFERENCE ANNOUNCEMENT

     International Conference on Stimulating Research and Development for
     Neglected Diseases

     Organised by M�decins Sans Fronti�res and the London School of
     Economics and Political Science

     London 14 - 15 June 2001

     M�decins Sans Fronti�res and the London School of Economics and
     Political Science are organising a one and a half day international
     conference on stimulating research and development for medicines for
     neglected diseases. The conference will take place in London 14-15
     June.

     Infectious diseases kill 15 million people every year. Over 95 % of
     these deaths occur in the developing world. Despite growing disease
     burden in poor countries, drug research and development targeted at
     the major infectious diseases has not been significantly advanced -
     only a few per cent of the world-wide expenditure on health R&D is
     devoted to these diseases.

     It is clear that the market has not adequately addressed or delivered
     drugs for neglected diseases such as malaria, sleeping sickness,
     kala-azar and tuberculosis. In the absence of significant private
     sector engagement, which global strategies can be deployed to relaunch
     serious R&D efforts towards effective and affordable drugs for
     neglected diseases?

     This conference is convened to examine the state of research and
     development for neglected diseases and discuss the respective roles
     and responsibilities of national governments (in developed and
     developing countries), international organisations, universities, the
     multinational pharmaceutical industry and funders (such as private
     foundations).

     Define working principles emerging from ongoing public/private
     partnerships to stimulate R&D and examine how these may be built upon
     and improved.

     As seating is restricted please contact Ms. Mali Nilsson for
     an invitation by May 18.

     Ms. Mali Nilsson
     Email: conference@london.msf.org

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.